Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORIGIN: Insulin Glargine and Omega-3 in Early Diabetes/Prediabetes
NCT00069784Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2003
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 40
01
Overview
A Phase 3 trial of insulin glargine, omega-3-acid triglycerides in type 2 diabetes mellitus (T2DM), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), sponsored by Sanofi. Started Aug 2003; status: completed.
02
Drugs
insulin glargineomega-3-acid triglycerides
03
Conditions
type 2 diabetes mellitus (T2DM)impaired fasting glucose (IFG)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00069784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069784.